These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6946849)

  • 41. Role of ERK activation in growth and erythroid differentiation of K562 cells.
    Woessmann W; Mivechi NF
    Exp Cell Res; 2001 Apr; 264(2):193-200. PubMed ID: 11262176
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of hemoglobin accumulation by monoclonal antibodies to the human transferrin receptor is reversed by hemin.
    Viola L; Biagini R; Barbieri R; Gambari R
    Exp Hematol; 1987 Dec; 15(11):1145-52. PubMed ID: 2445597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification and conditions for selective expression of megakaryocytic markers in Friend erythroleukemia cells.
    Paoletti F; Vannucchi AM; Mocali A; Caporale R; Burstein SA
    Blood; 1995 Oct; 86(7):2624-31. PubMed ID: 7670106
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Isolation and characterization of murine erythroleukemia cell variants nonresponsive to hemin for the expression of globin genes.
    Manduca P
    Somatic Cell Genet; 1981 Jan; 7(1):11-26. PubMed ID: 6939141
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of differentiation-inducing agents on oncogene expression in a chronic myelogenous leukemia cell line.
    Eisbruch A; Blick M; Evinger-Hodges MJ; Beran M; Andersson B; Gutterman JU; Kurzrock R
    Cancer; 1988 Sep; 62(6):1171-8. PubMed ID: 3044574
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hemin control of heme biosynthesis in mouse Friend virus-transformed erythroleukemia cells in culture.
    Granick JL; Sassa S
    J Biol Chem; 1978 Aug; 253(15):5402-6. PubMed ID: 276528
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential hemoglobin synthesis in murine erythroleukemic cells: hemin effects.
    Zucker RM; Umlas ME; Decal DL; Whittington KB
    Cell Biochem Funct; 1987 Jan; 5(1):27-35. PubMed ID: 3469035
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deficient heme synthesis as the cause of noninducibility of hemoglobin synthesis in a Friend erythroleukemia cell line.
    Rutherford TR; Weatherall DJ
    Cell; 1979 Feb; 16(2):415-23. PubMed ID: 287566
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spontaneous delta- to beta-globin switching in K562 human leukemia cells.
    Mookerjee B; Arcasoy MO; Atweh GF
    Blood; 1992 Feb; 79(3):820-5. PubMed ID: 1732019
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ETS-1 induces increased expression of erythroid markers in the pluripotent erythroleukemic cell lines K562 and HEL.
    Clausen PA; Athanasiou M; Chen Z; Dunn KJ; Zhang Q; Lautenberger JA; Mavrothalassitis G; Blair DG
    Leukemia; 1997 Aug; 11(8):1224-33. PubMed ID: 9264374
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term cultivation and differentiation of human erythroleukemia cells in a protein-free chemically defined medium.
    Okabe T; Fujisawa M; Takaku F
    Proc Natl Acad Sci U S A; 1984 Jan; 81(2):453-5. PubMed ID: 6582502
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction of calcium-activated potassium channel activity by hemin in human erythroleukemia cells.
    Huang CC; Hall AC; Lim PH
    Life Sci; 2004 Jun; 75(3):329-38. PubMed ID: 15135653
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of "fetal-type" acetylcholinesterase in hemin-treated K562 cell culture.
    Bartha E; Oláh E; Szelényi JG; Hollan SR
    Blood Cells; 1987; 12(3):647-55. PubMed ID: 3477301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression and induction of cathepsins B and D in K562 cells.
    Murnane MJ; Phipps PM; Denekamp DS
    Exp Hematol; 1988 Jan; 16(1):33-7. PubMed ID: 3335232
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of transforming growth factor-beta 1 on proliferation and induction of hemoglobin accumulation in K-562 cells.
    Chen LL; Dean A; Jenkinson T; Mendelsohn J
    Blood; 1989 Nov; 74(7):2368-75. PubMed ID: 2804370
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The proportions of hemoglobin types induced in mouse erythroleukemia cells vary with the inducer or combination of inducers, the inducer concentration and the time of induction.
    Scher W; Scher BM; Hellinger N; Waxman S
    Hemoglobin; 1985; 9(6):577-96. PubMed ID: 3912357
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A possible effect of heme on the fate of DNA ligase activity extracted from differentiating mouse erythroleukemia cells.
    Scher BM; Scher W; Waxman S
    Cancer Res; 1988 Nov; 48(22):6278-84. PubMed ID: 3180046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanism of differentiation of human erythroleukaemic cell line K562 by hemin.
    Baliga BS; Mankad M; Shah AK; Mankad VN
    Cell Prolif; 1993 Nov; 26(6):519-29. PubMed ID: 9116119
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of red cell antigens by K562 human leukemia cells before and after induction of hemoglobin synthesis by hemin.
    McGinniss MH; Dean A
    Transfusion; 1985; 25(2):105-9. PubMed ID: 3856962
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of erythroid differentiation of human K562 cells by cisplatin analogs.
    Bianchi N; Ongaro F; Chiarabelli C; Gualandi L; Mischiati C; Bergamini P; Gambari R
    Biochem Pharmacol; 2000 Jul; 60(1):31-40. PubMed ID: 10807942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.